AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

POLAR CAPITAL GLOBAL HEALTH.TST PLC

Transaction in Own Shares Dec 1, 2025

5198_tar_2025-12-01_6ce69599-3033-40f1-b701-fc2117252705.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 6649J

Polar Capital Global Health Tst PLC

01 December 2025

THE INFORMATION CONTAINED IN THIS ANNOUNCEMENT IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION IN WHOLE OR IN PART IN CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE ITS RELEASE, PUBLICATION OR DISTRIBUTION IS OR MAY BE UNLAWFUL. 

LEI: 549300YV7J2TWLE7PV84

1 December 2025

Polar Capital Global Healthcare Trust plc (the "Company")

Tender Price

Subsequent to the proposals set out in the Circular to Shareholders published on 22 October 2025 (the "Circular"), which were approved at the General Meeting held on 27 November 2025, the Company today announces the Tender Price at which the Ordinary Shares tendered will be repurchased by the Company.

The number of Ordinary Shares in issue excluding shares held in treasury and therefore available to be tendered was 121,270,000; of these, 27,253,026 shares were validly tendered equating to 22.47% of the issued share capital excluding shares held in treasury.

The Tender Price per Ordinary Share is 425.61 pence, being equal to the NAV per Share as at the close of business on 27 November 2025 less the Tender Offer Expenses per Share.

In accordance with the terms of the proposals and the resolutions passed by Shareholders at the General Meeting, the shares validly tendered will be placed into treasury and will be available for reissue into the market from 2 December 2025. For a short period of time, the price at which such shares may be reissued will be calculated at a premium to the Tender Price but may be at a discount to the NAV.

EXPECTED TIMETABLE OF EVENTS

Calculation Date Close of business on

27 November 2025
Announcement of final results of the Tender Offer and the Tender Price 1 December 2025
Repurchase of Shares pursuant to the Tender Offer 2 December 2025
Tendered Shares available for reissue 2 December 2025
CREST accounts credited in respect of Tender Offer proceeds for uncertificated Ordinary Shares by 5 December 2025
Cheques despatched in respect of Tender Offer proceeds for certificated Ordinary Shares by 12 December 2025
Despatch of balancing share certificates (in respect of certificated Shares) for revised, certificated holdings by 12 December 2025

Each of the times and dates in the expected timetable above may be extended or brought forward without further notice. If any of the above times and/or dates change, the revised time(s) and/or date(s) will be notified to Shareholders by a Regulatory Information Service announcement. All references are to London time (GMT) unless otherwise stated.

The full text of the Proposals and of the resolutions proposed to Shareholders was set out in the Circular to Shareholders dated and published on 22 October 2025, and is available on the Company's website at: https://www.polarcapitalglobalhealthcaretrust.co.uk/.

Capitalised terms shall have the meaning attributed to them in the Circular unless otherwise defined in this announcement.

For further information please contact: Lisa Arnold - Chair

Polar Capital Global Healthcare Trust plc

(contact via the Company Secretary)

John 'Reg' Regnier-Wilson / Richard Oates

Polar Capital

Investment Trust Sales

Alex Collins / Michael Janes / Ashwin Kohli

Panmure Liberum Limited

Corporate Broker
Tel. 020 7227 2742

Tel. 020 7227 2725

Tel. 020 3100 2000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TENPKDBNCBDKNBK

Talk to a Data Expert

Have a question? We'll get back to you promptly.